[go: up one dir, main page]

DZ2479A1 - Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant. - Google Patents

Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.

Info

Publication number
DZ2479A1
DZ2479A1 DZ980089A DZ980089A DZ2479A1 DZ 2479 A1 DZ2479 A1 DZ 2479A1 DZ 980089 A DZ980089 A DZ 980089A DZ 980089 A DZ980089 A DZ 980089A DZ 2479 A1 DZ2479 A1 DZ 2479A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical compositions
compositions containing
inhibitor compounds
inflammatory selective
inflammatory
Prior art date
Application number
DZ980089A
Other languages
English (en)
Inventor
Kristin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DZ2479A1 publication Critical patent/DZ2479A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
DZ980089A 1997-05-05 1998-03-02 Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant. DZ2479A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
DZ2479A1 true DZ2479A1 (fr) 2003-02-01

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980089A DZ2479A1 (fr) 1997-05-05 1998-03-02 Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.

Country Status (32)

Country Link
EP (1) EP0988034A1 (fr)
JP (1) JP2000513020A (fr)
KR (2) KR20010012300A (fr)
CN (1) CN1255059A (fr)
AP (1) AP9801234A0 (fr)
AR (2) AR011726A1 (fr)
AU (1) AU6932198A (fr)
BG (1) BG103852A (fr)
BR (1) BR9808720A (fr)
CA (1) CA2288759A1 (fr)
DZ (1) DZ2479A1 (fr)
EA (1) EA003696B1 (fr)
GT (1) GT199800063A (fr)
HR (1) HRP980244A2 (fr)
HU (1) HUP0001286A3 (fr)
ID (1) ID21311A (fr)
IL (1) IL132570A0 (fr)
IS (1) IS5220A (fr)
MA (1) MA26491A1 (fr)
NO (1) NO995389L (fr)
NZ (1) NZ500183A (fr)
OA (1) OA11213A (fr)
PA (1) PA8450601A1 (fr)
PE (1) PE72599A1 (fr)
PL (1) PL337003A1 (fr)
SK (1) SK148199A3 (fr)
TN (1) TNSN98059A1 (fr)
TW (1) TW590773B (fr)
UY (1) UY24989A1 (fr)
WO (1) WO1998050033A1 (fr)
YU (1) YU55899A (fr)
ZA (1) ZA983722B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
EP1123091A1 (fr) * 1998-10-23 2001-08-16 Merck Frosst Canada & Co. Produit de combinaison comprenant un ligand de prostaglandine de type e et un inhibiteur selectif de cox-2, et procedes d'utilisation dudit produit
EP1637137A3 (fr) * 1999-03-10 2006-07-05 G.D. Searle LLC Méthode et composition se rapportant à l'administration d'un inhibiteure de la cyclooxygénase-2 aux animaux
WO2001034204A1 (fr) * 1999-11-11 2001-05-17 Eli Lilly And Company Produits composes oncolytiques destines au traitement du cancer
JP2004521856A (ja) * 2000-05-15 2004-07-22 メルク フロスト カナダ アンド カンパニー Cox−2選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物
CA2411960C (fr) 2000-06-13 2010-10-12 Wyeth Compositions analgesiques et anti-inflammatoires contenant des inhibiteurs de cox-2
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
EP1307538B1 (fr) 2000-08-07 2009-01-07 Vanderbilt University Detection de l'activite cox-2 et des metabolites d'anandamide
WO2003007875A2 (fr) * 2001-07-16 2003-01-30 Hoegestaett Edward Substances organoleptiques d'acetaminophene et composes associes utilises comme substrats pour conjugaison d'acides gras et utilisation de ces substances dans le traitement de la douleur, de la fievre et des inflammations
DK1534305T3 (da) 2003-05-07 2007-02-05 Osteologix As Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte
CA2533101A1 (fr) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Formulation dispersable d'un agent anti-inflammatoire
US20080269310A1 (en) * 2005-05-20 2008-10-30 Adrian Paul Foster Synergistic Combinations
DK2079456T3 (da) 2007-04-04 2013-03-18 Sigmoid Pharma Ltd Farmaceutiske cyclosporinsammensætninger
EP2061587A1 (fr) 2007-04-26 2009-05-27 Sigmoid Pharma Limited Fabrication de minicapsules multiples
BRPI1012196B1 (pt) 2009-05-18 2021-11-30 Sublimity Therapeutics Limited Composição compreendendo gotas de óleo
EP2464341B1 (fr) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Compositions immunomodulatrices comprenant une matrice polymère et une phase huileuse
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
ES2907285T3 (es) 2014-03-06 2022-04-22 Elanco Animal Health Incorporated Composiciones de grapiprant y procedimientos de uso de las mismas
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
KR20170102223A (ko) 2014-11-07 2017-09-08 시그모이드 파마 리미티드 사이클로스포린을 포함하는 조성물
CA2972996A1 (fr) * 2015-01-09 2016-07-14 Jaguar Animal Health Methodes de traitement de la diarrhee chez des animaux de compagnie
EP4125874A4 (fr) * 2020-03-25 2024-05-01 SRI International Inhibiteurs de lipoxygénase
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes

Also Published As

Publication number Publication date
EA003696B1 (ru) 2003-08-28
ID21311A (id) 1999-05-20
HUP0001286A2 (hu) 2000-11-28
YU55899A (sh) 2003-08-29
AP9801234A0 (en) 1999-11-04
WO1998050033A1 (fr) 1998-11-12
IL132570A0 (en) 2001-03-19
MA26491A1 (fr) 2004-12-20
HUP0001286A3 (en) 2000-12-28
PL337003A1 (en) 2000-07-31
JP2000513020A (ja) 2000-10-03
UY24989A1 (es) 2001-10-25
TNSN98059A1 (fr) 2005-03-15
OA11213A (en) 2003-07-14
IS5220A (is) 1999-10-19
BG103852A (en) 2000-06-30
PA8450601A1 (es) 2000-05-24
ZA983722B (en) 1999-11-04
PE72599A1 (es) 1999-08-12
NO995389L (no) 2000-01-04
EA199900895A1 (ru) 2000-06-26
KR20010012300A (ko) 2001-02-15
NO995389D0 (no) 1999-11-04
AU6932198A (en) 1998-11-27
CN1255059A (zh) 2000-05-31
TW590773B (en) 2004-06-11
BR9808720A (pt) 2000-07-11
AR039628A2 (es) 2005-03-02
AR011726A1 (es) 2000-08-30
SK148199A3 (en) 2001-09-11
HRP980244A2 (en) 1999-02-28
EP0988034A1 (fr) 2000-03-29
NZ500183A (en) 2002-04-26
CA2288759A1 (fr) 1998-11-12
GT199800063A (es) 1999-10-26
KR20040004406A (ko) 2004-01-13

Similar Documents

Publication Publication Date Title
DZ2479A1 (fr) Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.
DZ1916A1 (fr) Composés nouveaux et compostions pharmaceutiques les contenant.
DZ2086A1 (fr) Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
DZ2461A1 (fr) Dérivés d'arylkylamines nouveaux et composition pharmaceutiques les contenant.
MA26537A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
DZ2361A1 (fr) Dérivés de 6-phénylpyridyl-2-amine et compositionspharmaceutiques les contenant
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
MA24466A1 (fr) Compositions contenant de la tetrahydrolistatine
DZ2978A1 (fr) Composés chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
CY2012029I1 (el) Νεα μορφη της s-ομεπραζολης
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
BR1100403A (pt) Composto e composição farmacêutica de inibidores de cox-2
NO980546D0 (no) Farmasöytiske midler
DE69841155D1 (de) Emulsionzusammensetzung
MA26486A1 (fr) Aryl- et heteroaryl-thiazolocetohydrazides inhibiteurs de proteases, et compositions pharmaceutiques les contenant .
MA26492A1 (fr) Inhibiteurs de proteases nouveaux et compositions pharmaceutiques les contenant .
ATE268758T1 (de) Hypolipidämische propanolaminderivate
DZ2609A1 (fr) Composés nouveaux antagonistes des récepteurs de vitronectine et compositions pharmaceutiques les contenant.
IS5331A (is) Ný lyfjablanda
ID29294A (id) Komposisi farmasi
MA26531A1 (fr) Composition pharmaceutique
ITMI950379A0 (it) Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico